DDR on DTC: Simponi

Share this article:
Some DTC ads develop from a key consumer insight that points to brand essence and leads to a great creative idea. Some come from a unique feature or benefit that triggers an equally unique concept. Some, however, come from a detail aid. The new campaign for J&J's Simponi looks like one of the latter.

Here is a wonderful drug that relieves the pain of rheumatoid arthritis (RA) and makes life better for sufferers. But what do we see? A carousel on the beach. And then we go shoe shopping. What's the connection? And, more importantly, how does it relate to RA relief? The lack of an announcer makes it even harder to follow the story. All I could think was that there must be a detail aid with a carousel and maybe some shoes on it with which the ad is supposed to “synergize.” Unfortunately, consumers rarely see detail aids.

The Simponi DTC campaign has a number of good parts, but they all seem to be coming from different brands. The imagery and storyline are not threaded together in a way that makes sense. However, like a traditional “professional” campaign, it leverages its brand symbols at every possible touch-point. The carousel and the shoes are there, but we're just not sure what they mean. The production values are nice, everyone looks good and the TV ad is memorable—though perhaps a bit off. All things considered, I was left wondering where I could get those cute, red shoes.

Deborah Dick-Rath is SVP, healthcare practice leader, at FactorTG. Contact: deborah.dick-rath@factortg.com
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.